{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:59:03Z","timestamp":1793761143480,"version":"4.6.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.toxicon.2025.108237","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T01:15:55Z","timestamp":1736471755000},"page":"108237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["An update on botulinum toxin treatment of painful diabetic neuropathy, post-traumatic painful neuropathy\/neuralgia, post-herpetic neuralgia and occipital neuralgia"],"prefix":"10.1016","volume":"255","author":[{"given":"Bahman","family":"Jabbari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava","family":"Tohidian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.toxicon.2025.108237_bib1","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/AJP.0b013e31827a72d2","article-title":"Botulinum toxin A in postherpetic neuralgia: a parallel, randomized, double-blind, single-dose, placebo-controlled trial","volume":"29","author":"Apalla","year":"2013","journal-title":"Clin. J. Pain"},{"issue":"6","key":"10.1016\/j.toxicon.2025.108237_bib2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1474-4422(16)00017-X","article-title":"Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial","volume":"15","author":"Attal","year":"2016","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.toxicon.2025.108237_bib3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S1474-4422(18)30071-1","article-title":"Diagnosis and assessment of neuropathic pain through questionnaires","volume":"17","author":"Attal","year":"2018","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.toxicon.2025.108237_bib4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.phm.0000176339.73591.d7","article-title":"Treatment of pain attributed to plantar fasciitis with botulinum toxin a: a short-term, randomized, placebo-controlled, double-blind study","volume":"84","author":"Babcock","year":"2005","journal-title":"Am. J. Phys. Med. Rehabil."},{"issue":"2","key":"10.1016\/j.toxicon.2025.108237_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00702-004-0265-1","article-title":"Botulinum toxin type A in experimental neuropathic pain","volume":"112","author":"Bach-Rojecky","year":"2005","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.toxicon.2025.108237_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108668","article-title":"Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain","volume":"259","author":"Bagues","year":"2024","journal-title":"Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.toxicon.2025.108237_bib7","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00702-015-1384-6","article-title":"High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis","volume":"122","author":"Baricich","year":"2015","journal-title":"J. Neural. Transm."},{"issue":"1\u20132","key":"10.1016\/j.toxicon.2025.108237_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pain.2009.06.001","article-title":"A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory symptoms","volume":"146","author":"Baron","year":"2009","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.toxicon.2025.108237_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MED.0b013e328014979e","article-title":"Diabetic neuropathy: classification, measurement and treatment","volume":"14","author":"Boulton","year":"2007","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"1","key":"10.1016\/j.toxicon.2025.108237_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/apmr.2003.50070","article-title":"Treatment with botulinum toxin type B for upper-limb spasticity","volume":"84","author":"Brashear","year":"2003","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"2","key":"10.1016\/j.toxicon.2025.108237_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2217\/pmt.13.75","article-title":"Botulinum toxin for neuropathic pain and spasticity: an overview","volume":"4","author":"Brown","year":"2014","journal-title":"Pain Manag."},{"issue":"6","key":"10.1016\/j.toxicon.2025.108237_bib12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","article-title":"Diabetic neuropathy: clinical manifestations and current treatments","volume":"11","author":"Callaghan","year":"2012","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.toxicon.2025.108237_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/AJP.0b013e318255c132","article-title":"OnabotulinumtoxinA improves tactile and mechanical pain perception in painful diabetic polyneuropathy","volume":"29","author":"Chen","year":"2013","journal-title":"Clin. J. Pain"},{"issue":"5","key":"10.1016\/j.toxicon.2025.108237_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41394-019-0221-9","article-title":"Treatment of at-level spinal cord injury pain with botulinum toxin A","author":"Chun","year":"2019","journal-title":"Spinal Cord Ser Cases"},{"issue":"9","key":"10.1016\/j.toxicon.2025.108237_bib15","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/01.wnl.0000183055.81056.5c","article-title":"Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia","volume":"65","author":"Comella","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.toxicon.2025.108237_bib16","first-page":"608","article-title":"Botulinum as a toxin for treating post-herpetic neuralgia","volume":"46","author":"Ding","year":"2017","journal-title":"Iran. J. Public Health"},{"issue":"5","key":"10.1016\/j.toxicon.2025.108237_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11916-014-0411-x","article-title":"Occipital neuralgia","volume":"18","author":"Dougherty","year":"2014","journal-title":"Curr. Pain Headache Rep."},{"issue":"5\u20136","key":"10.1016\/j.toxicon.2025.108237_bib18","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00702-022-02494-5","article-title":"Botulinum toxin therapy: past, present and future developments","volume":"129","author":"Dressler","year":"2022","journal-title":"J. Neural. Transm."},{"issue":"5","key":"10.1016\/j.toxicon.2025.108237_bib19","first-page":"323","article-title":"The efficacy of intradermal injection of botulinum toxin in patients with post-herpetic neuralgia","volume":"13","author":"Emad","year":"2011","journal-title":"Iran. Red Crescent Med. J."},{"issue":"1","key":"10.1016\/j.toxicon.2025.108237_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1152\/physrev.00045.2019","article-title":"Neuropathic Pain: From Mechanisms to Treatment","volume":"101","author":"Finnerup","year":"2021","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.toxicon.2025.108237_bib20","first-page":"106","article-title":"The effects of intradermal botulinum toxin type a injections on pain symptoms of patients with diabetic neuropathy","volume":"19","author":"Ghasemi","year":"2014","journal-title":"J. Res. Med. Sci."},{"issue":"4","key":"10.1016\/j.toxicon.2025.108237_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clineuro.2010.11.021","article-title":"The importance of the greater occipital nerve in the occipital and the suboccipital region for nerve blockade and surgical approaches--an anatomic study on cadavers","volume":"113","author":"G\u00fcven\u00e7er","year":"2011","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.toxicon.2025.108237_bib22","first-page":"258","article-title":"Occipital neuralgia","volume":"15","author":"Hammond","year":"1978","journal-title":"Clin. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.toxicon.2025.108237_bib23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/ana.24605","article-title":"Botulinum toxin type A for neuropathic pain in patients with spinal cord injury","volume":"79","author":"Han","year":"2016","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.toxicon.2025.108237_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13181","article-title":"Subcutaneous botulinum toxin-A injection for treating postherpetic neuralgia","volume":"33","author":"Hu","year":"2020","journal-title":"Dermatol. Ther."},{"issue":"12","key":"10.1016\/j.toxicon.2025.108237_bib26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ncpneuro0948","article-title":"Botulinum neurotoxins in the treatment of refractory pain","volume":"4","author":"Jabbari","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.toxicon.2025.108237_bib27","series-title":"Botulinum Toxin Treatment of Pain Disorders","author":"Jabbari","year":"2022"},{"key":"10.1016\/j.toxicon.2025.108237_bib28","series-title":"Botulinum Toxin Treatment in Pain Disorders","author":"Jabbari","year":"2022"},{"issue":"7","key":"10.1016\/j.toxicon.2025.108237_bib29","first-page":"48","article-title":"Subcutaneous injection of botulinum toxin in patients with post herpetic neuralgia. A preliminary study","volume":"66","author":"Jain","year":"2018","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.toxicon.2025.108237_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.toxicon.2017.09.003","article-title":"An update on new and unique uses of botulinum toxin in movement disorders","volume":"147","author":"Jankovic","year":"2018","journal-title":"Toxicon"},{"issue":"6","key":"10.1016\/j.toxicon.2025.108237_bib31","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/brain\/awab079","article-title":"Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management","volume":"144","author":"Jensen","year":"2021","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.toxicon.2025.108237_bib32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1533-2500.2007.00150.x","article-title":"Botulinum toxin occipital nerve block for the treatment of severe occipital neuralgia: a case series","volume":"7","author":"Kapural","year":"2007","journal-title":"Pain Pract."},{"issue":"5","key":"10.1016\/j.toxicon.2025.108237_bib33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3390\/toxins13050332","article-title":"Botulinum toxin type-A (Botulax\u00ae) treatment in patients with intractable chronic occipital neuralgia: a pilot study","volume":"13","author":"Kim","year":"2021","journal-title":"Toxins"},{"issue":"1\u20133","key":"10.1016\/j.toxicon.2025.108237_bib34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pain.2009.08.023","article-title":"Incidence of facial pain in the general population","volume":"147","author":"Koopman","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.toxicon.2025.108237_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.587771","article-title":"Neurobiological after-effects of low intensity transcranial electric stimulation of the human nervous system: from basic mechanisms to metaplasticity","volume":"12","author":"Korai","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.toxicon.2025.108237_bib36","series-title":"Clinical Anatomy of the Cervical Spine","first-page":"127","article-title":"Musculature","author":"Lang","year":"1993"},{"issue":"2","key":"10.1016\/j.toxicon.2025.108237_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1586\/14737175.1.2.143","article-title":"Botulinum toxin type B (Myobloc, NeuroBloc): a new choice in cervical dystonia","volume":"1","author":"Lew","year":"2001","journal-title":"Expert Rev. Neurother."},{"issue":"8","key":"10.1016\/j.toxicon.2025.108237_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/srt.13867","article-title":"Peripheral and central pathogenesis of postherpetic neuralgia","volume":"30","author":"Liu","year":"2024","journal-title":"Skin Res. Technol."},{"key":"10.1016\/j.toxicon.2025.108237_bib39","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2147\/JPR.S442595","article-title":"Update on treating painful diabetic peripheral neuropathy: a review of current US guidelines with a focus on the most recently approved management options","volume":"17","author":"Mallick-Searle","year":"2024","journal-title":"J. Pain Res."},{"issue":"2","key":"10.1016\/j.toxicon.2025.108237_bib40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/ane.13533","article-title":"Treatment of occipital neuralgia using onabotulinum toxin A","volume":"145","author":"Marcolla","year":"2022","journal-title":"Acta Neurol. Scand."},{"issue":"1\u20132","key":"10.1016\/j.toxicon.2025.108237_bib41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-3959(00)00481-4","article-title":"The density of remaining nerve endings in human skin with and without postherpetic neuralgia after shingles","volume":"92","author":"Oaklander","year":"2001","journal-title":"Pain"},{"issue":"22","key":"10.1016\/j.toxicon.2025.108237_bib42","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.toxicon.2025.108237_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11916-021-00972-1","article-title":"Occipital neuralgia","volume":"25","author":"Pan","year":"2021","journal-title":"Curr. Pain Headache Rep."},{"issue":"9","key":"10.1016\/j.toxicon.2025.108237_bib44","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/toxins9090260","article-title":"Botulinum toxin for the treatment of neuropathic pain","volume":"9","author":"Park","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2025.108237_bib45","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2147\/IDR.S401972","article-title":"Effects of intradermal botulinum toxin injections on herpes zoster related neuralgia","volume":"16","author":"Peng","year":"2023","journal-title":"Infect. Drug Resist."},{"issue":"2","key":"10.1016\/j.toxicon.2025.108237_bib46","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum neurotoxins: biology, pharmacology, and toxicology","volume":"69","author":"Pirazzini","year":"2017","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.toxicon.2025.108237_bib47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American diabetes association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.toxicon.2025.108237_bib48","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ana.21427","article-title":"Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain","volume":"64","author":"Ranoux","year":"2008","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.toxicon.2025.108237_bib49","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/ana.25340","article-title":"Efficacy of botulinum toxin A for treating cramps in diabetic neuropathy","volume":"84","author":"Restivo","year":"2018","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.toxicon.2025.108237_bib50","first-page":"99","article-title":"The effects of botulinum toxin type A injection on pain symptoms, quality of life, and sleep quality of patients with diabetic neuropathy: a randomized double-blind clinical trial","volume":"18","author":"Salehi","year":"2019","journal-title":"Iran J Neurol"},{"issue":"19","key":"10.1016\/j.toxicon.2025.108237_bib51","first-page":"1818","article-title":"Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the Guideline Development","volume":"86","author":"Simpson","year":"2016","journal-title":"Subcommittee of the American Academy of Neurology"},{"issue":"2","key":"10.1016\/j.toxicon.2025.108237_bib52","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2340\/00015555-0609","article-title":"Severe post-herpetic neuralgia successfully treated with botulinum toxin A: three case reports","volume":"89","author":"Sotiriou","year":"2009","journal-title":"Acta Derm. Venereol."},{"issue":"2","key":"10.1016\/j.toxicon.2025.108237_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2024.104233","article-title":"Pharmacotherapy and noninvasive neurostimulation for neuropathic pain","volume":"53","author":"Spagna","year":"2024","journal-title":"Presse Med."},{"issue":"3","key":"10.1016\/j.toxicon.2025.108237_bib54","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1152\/jn.00848.2017","article-title":"Cutaneous afferent innervation of the human foot sole: what can we learn from single-unit recordings?","volume":"120","author":"Strzalkowski","year":"2018","journal-title":"J. Neurophysiol."},{"issue":"6","key":"10.1016\/j.toxicon.2025.108237_bib55","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.dsx.2020.09.019","article-title":"The Effect of Intradermal Botulinum Toxin a injections on painful diabetic polyneuropathy","volume":"14","author":"Taheri","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"9","key":"10.1016\/j.toxicon.2025.108237_bib56","first-page":"794","article-title":"Comparison of Botox with a Chinese type A botulinum toxin","volume":"113","author":"Tang","year":"2000","journal-title":"Chin Med J (Engl)."},{"issue":"9","key":"10.1016\/j.toxicon.2025.108237_bib57","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11916-023-01146-x","article-title":"Therapeutic strategies for postherpetic neuralgia: mechanisms, treatments, and perspectives","volume":"27","author":"Tang","year":"2023","journal-title":"Curr. Pain Headache Rep."},{"issue":"10","key":"10.1016\/j.toxicon.2025.108237_bib58","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1111\/j.1526-4610.2008.01089.x","article-title":"Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study","volume":"48","author":"Taylor","year":"2008","journal-title":"Headache"},{"issue":"5","key":"10.1016\/j.toxicon.2025.108237_bib59","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/j.pain.0000000000000491","article-title":"The Pain in Neuropathy Study (PiNS): a cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy","volume":"157","author":"Themistocleous","year":"2016","journal-title":"Pain"},{"issue":"14","key":"10.1016\/j.toxicon.2025.108237_bib60","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1212\/WNL.0000000000003789","article-title":"TOWER study investigators. Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: the TOWER study","volume":"88","author":"Wissel","year":"2017","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.toxicon.2025.108237_bib61","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/j.1526-4637.2010.01003.x","article-title":"Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia","volume":"11","author":"Xiao","year":"2010","journal-title":"Pain Med."},{"issue":"11","key":"10.1016\/j.toxicon.2025.108237_bib62","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin. Proc."},{"issue":"17","key":"10.1016\/j.toxicon.2025.108237_bib63","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/01.wnl.0000345968.05959.cf","article-title":"Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial","volume":"72","author":"Yuan","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2025.108237_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1265372","article-title":"Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment","volume":"14","author":"Zhu","year":"2024","journal-title":"Front. Endocrinol."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004101012500011X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004101012500011X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T11:21:20Z","timestamp":1739877680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004101012500011X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":64,"alternative-id":["S004101012500011X"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2025.108237","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An update on botulinum toxin treatment of painful diabetic neuropathy, post-traumatic painful neuropathy\/neuralgia, post-herpetic neuralgia and occipital neuralgia","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2025.108237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108237"}}